Today, the national press has highlighted that recent tests of the new version of Canvax´s pSpark® DNA Cloning systems have been successful, introducing significant progress and improvements over the original product.

As described in the article, pSpark® is based on a new technology for cloning blunt fragments from PCR or outcome of treatment of double-stranded DNA with restriction enzymes that generate blunt ends: «This technology facilitates the daily work of the researchers, who will perform easier, more efficient and less time-consuming DNA cloning,.»

For more information, read the full new here.